IDEAS home Printed from https://ideas.repec.org/a/spr/aphecp/v13y2015i2p135-147.html
   My bibliography  Save this article

The geko™ Electro-Stimulation Device for Venous Thromboembolism Prophylaxis: A NICE Medical Technology Guidance

Author

Listed:
  • Jennifer Summers
  • James Clinch
  • Muralikrishnan Radhakrishnan
  • Andy Healy
  • Viktoria McMillan
  • Elizabeth Morris
  • Tiago Rua
  • Mercy Ofuya
  • Yanzhong Wang
  • Paul Dimmock
  • Cornelius Lewis
  • Janet Peacock
  • Stephen Keevil

Abstract

The geko™ device is a single-use, battery-powered, neuromuscular electrostimulation device that aims to reduce the risk of venous thromboembolism (VTE). The National Institute for Health and Care Excellence (NICE) selected the geko™ device for evaluation, and invited the manufacturer, Firstkind Ltd, to submit clinical and economic evidence. King’s Technology Evaluation Centre, an External Assessment Centre (EAC) commissioned by the NICE, independently assessed the evidence submitted. The sponsor submitted evidence related to the geko™ device and, in addition, included studies of other related devices as further clinical evidence to support a link between increased blood flow and VTE prophylaxis. The EAC assessed this evidence, conducted its own systematic review and concluded that there is currently limited direct evidence that geko™ prevents VTE. The sponsor’s cost model is based on the assumption that patients with an underlying VTE risk and subsequently treated with geko™ will experience a reduction in their baseline risk. The EAC assessed this cost model but questioned the validity of some model assumptions. Using the EACs revised cost model, the cost savings for geko™ prophylaxis against a ‘no prophylaxis’ strategy were estimated as £197 per patient. Following a second public consultation, taking into account a change in the original draft recommendations, the NICE medical technologies guidance MTG19 was issued in June 2014. This recommended the adoption of the geko™ for use in people with a high risk of VTE and when other mechanical/pharmacological methods of prophylaxis are impractical or contraindicated in selected patients within the National Health Service in England. Copyright The Author(s) 2015

Suggested Citation

  • Jennifer Summers & James Clinch & Muralikrishnan Radhakrishnan & Andy Healy & Viktoria McMillan & Elizabeth Morris & Tiago Rua & Mercy Ofuya & Yanzhong Wang & Paul Dimmock & Cornelius Lewis & Janet Pe, 2015. "The geko™ Electro-Stimulation Device for Venous Thromboembolism Prophylaxis: A NICE Medical Technology Guidance," Applied Health Economics and Health Policy, Springer, vol. 13(2), pages 135-147, April.
  • Handle: RePEc:spr:aphecp:v:13:y:2015:i:2:p:135-147
    DOI: 10.1007/s40258-014-0139-0
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1007/s40258-014-0139-0
    Download Restriction: Access to full text is restricted to subscribers.

    File URL: https://libkey.io/10.1007/s40258-014-0139-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Iain Willits & Kim Keltie & Joyce Craig & Andrew Sims, 2014. "WatchBP Home A for Opportunistically Detecting Atrial Fibrillation During Diagnosis and Monitoring of Hypertension: A NICE Medical Technology Guidance," Applied Health Economics and Health Policy, Springer, vol. 12(3), pages 255-265, June.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Abubakar Ibrahim Jatau & Luke R. Bereznicki & Barbara C. Wimmer & Woldesellassie M. Bezabhe & Gregory M. Peterson, 2022. "Improving Knowledge and Early Detection of Atrial Fibrillation through a Community-Based Opportunistic Screening Program: What’s Your Beat?," IJERPH, MDPI, vol. 19(11), pages 1-12, June.
    2. Ailish Higgins & Matthew Glover & Yaling Yang & Susan Bayliss & Catherine Meads & Joanne Lord, 2014. "EXOGEN Ultrasound Bone Healing System for Long Bone Fractures with Non-Union or Delayed Healing: A NICE Medical Technology Guidance," Applied Health Economics and Health Policy, Springer, vol. 12(5), pages 477-484, October.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:aphecp:v:13:y:2015:i:2:p:135-147. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.